Ge
No verificado

Genentech

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud
10/11/2026
Eventos
Industria
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Sanidad
Genentech and Roche Present New Data Across Pharmaceuticals and Diagnostics From Its Growing Alzheimer’s Disease Portfolio at CTAD 2026
1.00
25/10/2026
Oncología
Salud
Medicina - Varios
Sanidad
Farmacéutica
Biotecnología
Industria
Genentech’s Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer
1.00
23/10/2026
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
Genentech Presents Interim Phase III Data Showing Sefaxersen Significantly Reduced Proteinuria in People With IgA Nephropathy (IgAN)
1.00
21/10/2026
Oncología
Salud
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Ferias y Congresos
Industria
Genentech Presents New Pivotal Trial Data Across Broad Neuroimmunology Portfolio at MSToronto2026
1.00
19/10/2026
Oncología
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Eventos
Industria
Genentech to Present Pivotal Data at ESMO 2026, Showcasing Advances Across Its Lung and Breast Cancer Late-Stage Portfolio
1.00
16/10/2026
Ciencia
Higiene alimentaria
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
Óptica
Industria
FDA Approves Genentech’s Enspryng, a First-in-Class IL-6R Inhibitor, as the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
1.00
10/10/2026
Ciencia
Biotecnología
Farmacéutica
Óptica
Salud
Higiene alimentaria
Medicina - Varios
Industria
Genentech Presents New Phase III One-Year Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss
1.00
09/10/2026
Industria
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Farmacéutica
Biotecnología
FDA Approves Genentech’s Tecentriq in Combination With a Fluoropyrimidine and Oxaliplatin for the Adjuvant Treatment of a Certain Type of Stage III Colon Cancer
1.00
01/10/2026
Eventos
Industria
Ciencia
Biotecnología
Farmacéutica
Óptica
Salud
Higiene alimentaria
Medicina - Varios
Genentech Presents New Data at EURETINA, Highlighting Vabysmo’s Real-World Effectiveness and Safety Across Major Retinal Conditions
1.00

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0